Last edition
USFDA Gives Nod to Strides Pharma's Generic Drug for Seizures
Strides Pharma Science announced that its subsidiary has received approval from the US health regulator to market a generic medication for seizures.
Singapore-based Strides Pharma Global Pte Ltd has received approval for Levetiracetam Oral Solution USP, 100 mg/mL, from the US Food & Drug Administration (USFDA), the company said in a regulatory filing.
The approved product is bioequivalent and therapeutically equivalent to the reference listed drug Keppra Oral Solution of UCB, Inc, it added.
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy